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Gonococci express a family of related outer membrane proteins designated protein II (P.11), which undergo
both phase and antigenic variation. Six P.11 proteins have been identified in strain FA1090. We developed
monoclonal antibodies specific for each P.11 protein. Using these antibodies as probes, we purified the six
different P.11 proteins of this strain. Despite the relatedness of the proteins, we could not purify all of them by
a single purification scheme. Four P.11 proteins were purified by chromatofocusing, and the remaining two
proteins were purified by hydrophobic interaction chromatography on phenyl-Sepharose. The N-terminal
amino acid sequence of the proteins showed a high degree of sequence conservation. However, there was
variability at specific amino acid residues, giving each P.11 protein a unique N-terminal amino acid sequence.
Thus P.1I proteins of one strain differ among themselves not only in antigenic determinants and primary
structure, but also in other characteristics affecting their properties in different chromatographic systems.
The outer membrane protein antigens of Neisseria gonor-
rhoeae are highly variable.These variations may be impor-
tant in enabling the gonococcus to evade the host immune
response and to adapt to differing host environments. One
family of proteins that show such variation are the surface-
exposed proteins II (P.11), which rapidly and reversibly alter
expression within a single gonococcal strain and differ
antigenically among different strains (1, 17, 32). The P.11
proteins have apparent molecular weights of 24,000 to 30,000
and display a characteristic heat modifiability (an increase in
apparent molecular weight when solubilized at 100°C versus
37°C) on sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis (SDS-PAGE) (7, 17, 30). A single gonococcal strain
has been shown to express as many as seven P.II species,
which differ in apparent molecular weight and antigenicity
(23). A single organism may have zero to at least three P.IIs
on its surface simultaneously (1), and spontaneous switches
in P.11 expression occur at a high frequency (19). There is a
partial correlation of P.11 expression with colonial photo-
opacity phenotype (1, 30, 32, 34). Differences in colonial
opacity or in P.II expression also correlate with differences
in properties that may be related to virulence (6, 9, 10, 18).
P.11 proteins do vary in vivo, and gonococci lacking P.IIs are
believed to be more virulent and invasive than those express-
ing the proteins (9, 23, 24).
P.11 protein variants within the same strain or in different
strains possess considerable structural homology, as re-
vealed by tryptic peptide mapping (8, 12, 31) and immuno-
logical studies (33). However, different P.11 proteins from
one gonococcal strain possess several unique peptides, and
these are primarily surface exposed (8, 12, 31). Antisera or
monoclonal antibodies directed against presumed surface-
exposed portions of P.IIs are highly specific for the homol-
ogous P.11 variant (1, 5, 33).
Although procedures for the chromatographic purification
of P.IIs have been reported (2, 8, 21), there has been no
previous indication that the antigenic differences in individ-
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ual P.11 proteins of a single strain might be correlated with
structural differences affecting the behavior of the proteins in
different chromatographic systems. We report here that such
structural heterogeneity does occur and that it necessitates
the application of multiple purification schemes for the P.11
proteins. The generation of a repertoire of monoclonal
antibodies that could distinguish the P.1I proteins was an
essential first step in these studies.
MATERIALS AND METHODS
Bacterial strains. N. gonorrhoeae FA1090 is a serum-
resistant prototrophic strain that was isolated from a patient
with probable disseminated gonococcal infection (20). Other
gonococcal strains were from the collection of P. F. Sparl-
ing, University of North Carolina School of Medicine. All
neisserial strains were grown on GC medium base agar
(Difco Laboratories) with Kellogg defined supplements or in
GC broth plus supplements (13). Bacteria were incubated at
37°C in a 5% CO2 atmosphere. Colonial opacity variants
were identified by the criteria of Swanson (29).
Outer membrane preparation. Membranes used for P.11
purification were obtained from liquid cultures (2 to 8 liters)
of FA1090 gonococci expressing a single P.JI as determined
by SDS-PAGE and Western blotting (immunoblotting). Bac-
teria were grown to late log phase, harvested by centrifuga-
tion, and washed once in minimal broth, Davis (Difco).
Outer membranes were prepared by lithium acetate extrac-
tion (11). For mouse immunizations, outer membranes were
also prepared by Sarkosyl (CIBA-GEIGY Corp.) extraction
(34) of gonococci grown on GC medium base agar.
Production of hybridomas. Procedures for immunization of
BALB/c mice with gonococcal outer membranes (1), fusion
of spleen cells with SP2/0-Agl4 myeloma cells (22), and
screening of hybridomas by enzyme-linked immunosorbent
assay for antibody production (1), were essentially as de-
scribed previously. The antibody subclass was determined
by enzyme-linked immunosorbent assay or Ouchterlony
analysis with rabbit antibodies to mouse immunoglobulin
subclasses (Litton Bionetics).
Complement-dependent bactericidal activity of monoclo-
nal antibodies and colony blot radioimmunoassays, with
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hybridoma culture supernatant and radioiodinated protein A
(Amersham Corp.) to probe filter blots of gonococci, were
performed as described by Black et al. (1).
Electrophoresis and Western blotting. SDS-PAGE was
performed as previously described (1) with 4 to 30% linear
acrylamide gradient gels and the discontinuous buffer system
of Laemmli (16). Samples (20 to 50 jig) were solubilized at
100°C for 5 min or at 37°C for 60 min. Gels were stained with
Coomassie brilliant blue.
Western blotting and probing with monoclonal antibody
culture supernatants (diluted 1:5) or mouse serum (diluted
1:500 to 1:1,000) and 1251I-labeled protein A have been
previously described (1). Apparent molecular weights were
determined by comparison with iodinated protein molecular
weight standards (Pharmacia, Inc.), which were radioiodi-
nated with lodobeads (Pierce Chemical Co.).
Protein determination. Protein was quantitated by the
Bio-Rad protein assay with ovalbumin as standard (3).
Chromatofocusing chromatography. Outer membranes
were solubilized in 1% Nonidet P-40-25 mM triethylamine
(pH 11) (Sigma) for 30 min at 37°C and then centrifuged at
100,000 x g for 2 h. The soluble fraction from 15 to 20 mg of
outer membrane protein was subjected to PBE118 (Pharma-
cia) chromatofocusing chromatography essentially as de-
scribed by Newhall et al. (21), except that 1% Nonidet P-40
replaced Triton X-100 in all buffers. Proteins were eluted
with Pharmalyte 8-10.5 buffer (pH 7.0) (Pharmacia) diluted
1:45 (for P.IIb purification) or 1:30 (for all other P.11 pro-
teins). Fractions were assayed for the presence of P.JI by
SDS-PAGE and Western blotting, and the pH of column
fractions was measured. P.11-containing fractions were dia-
lyzed against 50 mM ammonium acetate (pH 9.5) at 4°C.
Dialysates were then treated in a manner similar to that
described by Blake and Gotschlich (2), involving precipita-
tion in 10% trichloroacetic acid, precipitation in ethanol, and
lyophilization. Pellets were washed three times in 85%
acetone-5% triethylamine-5% glacial acetic acid-5% H20
and lyophilized.
Phenyl-Sepharose chromatography. Hydrophobic interac-
tion chromatography was performed at room temperature on
5-ml (1 by 6.5 cm) columns of phenyl-Sepharose CL-4B
(Pharmacia). Columns were equilibrated with three bed
volumes of appropriate buffer. Flow rates were 0.5 ml/min,
and 1.5-ml fractions were collected.
For purification of P.IIc, outer membranes were solubil-
ized for 1 h at 37°C in 1.5% 3-[(3-cholamidopropyl)dimethyl-
ammonio]-1-propane sulfonate (CHAPS) (Sigma)-50 mM
sodium phosphate buffer (pH 7.5) at a protein concentration
of 10 mg/ml and centrifuged at 100,000 x g for 2 h. A 1-ml
portion of the soluble fraction was applied to a phenyl-
Sepharose column equilibrated in solubilization buffer plus 2
mM EDTA (buffer A). The column was eluted in a stepwise
fashion with 12 ml of each of the following buffers in
succession: buffer A; buffer A plus 0.5% Tween 20 (Sigma);
buffer A plus 1.5% Tween 20; and buffer A plus 3.0% Tween
20.
For purification of P.IId, outer membranes were solubil-
ized for 1 h at 37°C in 1% sodium cholate (Sigma)-1 M
NaCi-50 mM sodium phosphate buffer (pH 8.2) at a protein
concentration of 2 mg/ml and then centrifuged as above.
Triton X-100 (Research Products International) was added to
the P.IId-containing soluble fraction to a final concentration
of 0.75%. The soluble fraction was applied to a phenyl-
Sepharose column equilibrated in 1% sodium cholate-0.75%
Triton X-100-50 mM sodium phosphate buffer (pH 8.2). The
column was then washed with 12 ml of equilibration buffer
and eluted with a 50-ml buffer gradient of 1% cholate-0.75%
Triton X-100-50 mM sodium phosphate buffer to 1% cho-
late-3.0% Triton X-100-10 mM sodium phosphate buffer.
P.IIc- or P.IId-containing fractions were identified by
SDS-PAGE and Western blotting, and samples were proc-
essed as described for P.IIs purified by chromatofocusing.
Phenyl-Sepharose was regenerated by being washed with
distilled water, being subjected to a step gradient of increas-
ing ethanol concentration (5 to 95%), being treated with two
bed volumes of n-butanol, being subjected to a step gradient
of decreasing ethanol concentration (95 to 5%), being
washed with distilled water, and being equilibrated in 50 mM
sodium phosphate buffer. All columns were prepared from
regenerated phenyl-Sepharose exclusively.
Amino-terminal amino acid sequence analysis. Sequencing
was performed with an Applied Biosystems model 470A gas
phase sequencer with standard programs and automated
aqueous trifluoroacetic acid conversion to phenylthiohydan-
toin amino acids. Analysis of PTH amino acids was per-
formed on a gradient high-performance liquid chromato-
graph (Waters Associates, Inc.).
RESULTS
Monoclonal antibodies. Six electrophoretically distinct
forms of P.11 proteins, designated P.IIa through P.IIf, have
been identified for strain FA1090 (1). We previously reported
the production of two monoclonal antibodies, one specific
for P.IIa and one that binds to both P.IIb and P.IId (1, 28).
We generated three additional monoclonal antibodies spe-
cific for the remaining P.II proteins of FA1090 by using outer
membranes from colony variants expressing single P.II
proteins to immunize mice. Antibody specificity was deter-
mined by ELISA of P.II colony variants and by Western
blotting (Fig. 1; Table 1). The antibodies specific for P.IIc,
P.IIe, and P.IIf each bound to only a single P.11 protein and
recognized both the heat-modified and unmodified form of
the protein. None of these three antibodies was bactericidal
for appropriate P.11-expressing variants of FA1090.
We were unable to produce a monoclonal antibody that
could distinguish P.IIb from P.IId, despite several attempts
with different immunogens and immunization strategies. No
antibodies recognizing a common P.II epitope were gener-
ated in these fusions, suggesting that immunization with
outer membranes may not present common immunogenic
determinants to the mouse.
The FA1090 P.11-specific monoclonal antibodies were
tested for binding to a panel of 23 gonococcal strains by
colony blot radioimmunoassay. The strains included several
different serotypes isolated from people with uncomplicated
gonococcal infection or disseminated gonococcal infection.
Twenty of the strains showed no binding with any of the
antibodies; the remaining three strains bound one to three of
the five antibodies. The epitopes recognized by these mono-
clonal antibodies were thus not common to all gonococcal
strains, although they were not exclusively limited to strain
FA1090.
Using this panel of monoclonal antibodies, we could
unambiguously determine the P.11 expression state of any
colony variant of strain FA1090. Also, it was possible to
isolate and maintain colony variants with verified predomi-
nant expression of a single P.11 protein which facilitated
purification of the different P.11 proteins.
Purification of P.11 proteins by chromatofocusing. We ini-
tially used a modification of the chromatofocusing method
described by Newhall et al. (21), which takes advantage of
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TABLE 1. Characteristics of P.11 proteins and specificity of anti-
P.11 monoclonal antibodies
PIIvariant Mol Opacity Monoclonal ImmunoglobulinP. wta phenotypeb antibodyc subclasSd
P.IIa 30,000 Op++ H138 IgG3
P.11b 31,200 Tr H4 IgG2a
P.IIc 31,700 Tr H157 IgG3
P.IId 31,800 Op++ H4 IgG2a
P.IIe 31,900 Tr H164 IgG3
P.IIf 32,900 Op+ H156 IgG3
a Apparent molecular weight on 4 to 30% SDS-PAGE when solubilized at
100°C for 5 min.
b Opacity phenotype of FA1090 colonies. Abbreviations: Op+, very
* PU1b,d opaque; Op+, moderately opaque; Tr, transparent.
(H 4) c Monoclonal antibody specific for P.II protein.












FIG. 1. Electrophoresis and Western blot analysis of P.11 vari-
ants probed with P.11-specific monoclonal antibodies. (A) Coomas-
sie-stained 4 to 30% SDS-PAGE of FA1090 P.11 colony variants
expressing no P.11 (P.II-) or a single P.1I (P.IIa to P.11f). Outer
membranes (20 to 25 ,ug of protein) of each of the seven variants
were solubilized at 37°C for 60 min (left lane of each pair) and at
100°C for 5 min (right lane of each pair). This gel was one of five
replicates containing outer membranes of the same P.11 variants
prepared at different times. Each of the five gels was Western
transferred and probed with one of the anti-P.IT monoclonal anti-
bodies. (B to F) Autoradiographs of each Western blot. The mono-
clonal antibodies used for each probe, and their specificities, are
indicated to the right of each panel.
the high isoelectric point of P.11 proteins, to attempt purifi-
cation of the six P.IIs of FA1090. Four P.11 proteins (P.IIa,
P.IIb, P.IIe, and P.11f) were purified to apparent homogene-
ity by this method. There were some differences in the
behavior of the four proteins on the chromatofocusing col-
umn, since elution of P.IIa, P.IIe, and P.IIf required the use
of a more concentrated solution of Pharmalyte elution buffer
than elution of P.IIb did. Each of the P.II proteins was eluted
at a pH of approximately 9.5. The purification of P.IIa is
illustrated in Fig. 2. To demonstrate the purity of the
preparation, it was subjected to SDS-PAGE and Western
blotting and probed with a mixture of monoclonal antibodies
directed at different proteins of FA1090 plus mouse antisera
raised against outer membranes of all FA1090 P.11 variants.
Two of the P.11 proteins were refractory to purification by
this method. Solubilized P.IIc and P.IId remained bound to
the chromatofocusing column and could not be eluted under
any conditions tested. Alternative purification schemes were
necessary for these two proteins.
Hydrophobic interaction chromatography. Successful pu-
rification of P.IIc and P.IId was achieved by using bile salt
detergents to solubilize FA1090 outer membranes, followed
by combinations of detergents and changes in ionic strength
to selectively adsorb and elute P.11 proteins on phenyl-Se-
pharose.
Extraction of FA1090 P.IIc outer membranes with 1.5%
CHAPS (pH 7.5) buffer resulted in a soluble fraction en-
riched in P.IIc (30 to 40% of total membrane P.IIc) and
lacking protein I. This fraction was applied to a phenyl-
Sepharose column and eluted with a stepwise gradient of
CHAPS buffer plus increasing concentrations of Tween 20.
P.IIc eluted at a buffer composition of approximately 1.5%
CHAPS-1.5% Tween 20. P.IIc-containing fractions were
pooled, and the purity of the preparation was demonstrated
by SDS-PAGE and Western blot (Fig. 3). The yield of
purified protein was 1.65 mg from 20 mg of outer membrane
protein.
In contrast to P.IIc, P.IId was not extracted from outer
membranes by solubilization with bile salt detergents alone
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FIG. 2. Electrophoresis and Western blot analysis of P.IIa puri-
fication by chromatofocusing chromatography. (A) SDS-PAGE of
P.IIa outer membranes (OM), solubilized membrane fraction (S),
and purified P.Ia (P). Outer membranes (35 p.g) and solubilized
membrane fractions (50 jLg) were solubilized for electrophoresis at
100°C for 5 min. P.ITa samples (45 jig in each lane) were solubilized
at 100°C for 5 min or 37°C for 60 min. (B) Western blot of duplicate
samples on the same gel, probed with a mixture of FA1090-specific
monoclonal antibodies directed against all six P.I1 proteins, protein
I, and the H.8 protein (4) and with mouse antisera raised against
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FIG. 3. Electrophoresis and Westem blot analysis of the purifi-
cation of P.IIc on phenyl-Sepharose. (A) SDS-PAGE of P.IIc outer
membranes (OM), solubilized membrane fraction (S), and purified
P.IIc (P). Samples were solubilized for electrophoresis at 100°C for
5 min. (B) Western blot of duplicate samples on the same gel probed
with a mixture of antibodies as described in the legend to Fig. 2.
phosphate buffer (pH 7.5), no P.IId was detectable in the
soluble fraction, whereas a substantial portion of P.IIc was
extracted. The extraction of nearly all the other proteins was
identical in the two membrane preparations. The inclusion of
1 M NaCl in a buffer containing 1% sodium cholate resulted
in successful solubilization of P.IId. P.IId bound to phenyl-
Sepharose in an apparently irreversible fashion when ad-
sorbed in sodium cholate-NaCl buffer alone; it was eluted
only when Triton X-100 was included in the equilibration and
adsorption steps and the subsequent elution was done with a
gradient of increasing Triton concentration in 1% sodium
cholate. SDS-PAGE and Western blotting analyses of the
purified preparation are shown in Fig. 5. The yield of purified
P.IId was 1.63 mg from 8.0 mg of outer membrane protein.
The P.IId doublet seen after Coomassie staining was occa-
sionally present, for reasons we do not understand. It
occurred with some solubilization regimens, was generally
not present in the outer membrane samples, and appeared to
have no effect on the ability to determine amino acid
sequence.
All of the purified P.11 proteins retained their characteris-
tic heat modifiability, apparent molecular weight, and anti-
body-binding specificity on SDS-PAGE and Western blot-
ting.
Amino-terminal amino acid sequence. The N-terminal
amino acid sequence of each of the six P.11 proteins is shown
in Table 2. Although many residues were identical in all
P.IIs, each of the six proteins had a unique amino acid
sequence. Within the first 23 residues, there were differences
in the amino acids at positions 2, 4, 5, 8, 15, and 19. Not all
of the differences could be accounted for by mutations
involving single base pair changes in P.11 genes. The class of
the variable amino acids, based on the polarity of their side
chain groups, was not always conserved.
DISCUSSION
The objectives of this study were to characterize the
extent of antigenic and structural variability among the P.11
proteins made by one gonococcal strain. The occurrence of
antigenic differences among P.11 proteins has been docu-
mented (1, 17, 24, 32), but total number of antigenic variants
in a strain has not been determined. Using the set of
P.II-specific monoclonal antibodies, we showed that the six
P.1I proteins of strain FA1090 possessed at least five unique
epitopes. These monoclonal antibodies cross-reacted with
P.11 proteins of only a limited number of other gonococcal
strains. The antibodies probably recognized linear determi-
nants, since they bound to P.II proteins in whole organisms
or outer membranes and to the denatured proteins. The set
of monoclonal antibodies specific for each of the FA1090
P.IIs proved extremely useful in identifying and maintaining
colony variants of defined P.11 expression state, which was
essential for the purification of the individual P.11 proteins.
These antibodies should also be useful as tools in studies on
the functions of different P.11 proteins.
The N-terminal amino acid sequence of each of the six P.II
proteins was unique, although there was substantial conser-
vation of many residues. The residues conserved in the
FA1090 P.11 proteins were the same as those in other
sequenced P.11 proteins or P.II genes (2, 26, 27). Three of the
four previously available P.II N-terminal sequences are from
proteins or genes of strain MS11. Different strains within the
species N. gonorrhoeae can vary considerably, and it has
been suggested that strains causing disseminated gonococcal
infection, such as FA1090, may in fact represent a distinct
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FIG. 4. Differential solubilization of P.IIc and P.IId. The SDS-
PAGE profile of P.IIc and P.IId outer membranes solubilized at
37°C for 60 min in 1.5% CHAPS-50 mM sodium phosphate buffer
(pH 7.5) is shown. Samples (30 to 45 ,Lg) of soluble (S) and insoluble
(I) fractions were solubilized for electrophoresis at 100°C for 5 min.
Arrows indicate the location of P.11 proteins.
FIG. 5. Electrophoresis and Western blot analysis of the purifi-
cation of P.Ild on phenyl-Sepharose. (A) SDS-PAGE of P.Ild outer
membranes (OM), solubilized membrane fraction (S), and purified
P.Ild (P). Samples were solubilized for electrophoresis at 100°C for
5 min. (B) Western blot of duplicate samples of the same gel probed
with a mixture of antibodies as described in the legend to Fig. 2.
Stds S I S I
PlIc PHId
VOL. 55, 1987
2030 BARRITT ET AL.
TABLE 2. Amino-terminal amino acid sequences of FA1090 P.11 proteinsa
Amino-terminal amino acid sequence
P.II variant 5 10 15 20
P.Ia Ala- Ser-Glu-Asp- Gly-Gly-Arg- Gly-Pro-Tyr-Val
P.IIb Ala- Thr-Glu- Gly -Asn-Gly-Arg- Arg- Pro-Tyr-Val-Gln-Ala-Asp- Leu- Ala-Tyr-Ala- Ala-Glu-( )-Ile-Thr
P.IIc Ala- Ser-GIlu-Asp-Asn-Gly-( )- Gly- Pro-Tyr-Val-Gln-Ala-Asp- Lys- Ala-Tyr-Ala- Tyr-Glu
P.11d Ala- Ser-Glu- Gly -Asn- Gly-Arg- Gly- Pro-Tyr-Val-Gln-Ala-Asp- Leu- Ala-Tyr-Ala- Ala-Glu-Arg-Ile-Thr
P.Ie Ala-Gly-Glu-Asp-Asn-Gly-Arg
P.lif Ala-Thr-Glu-Asp-Asn-Gly-Arg
a Amino acids that were conserved in FA1090 P.11 proteins and in P.11 proteins of other strains are shown in boldface. All other amino acids were variable.
Positions 21 of P.11b and 7 of P.I1c were not determined.
believe that it is important to characterize the P.11 proteins
and the genes encoding them from more than a single
gonococcal strain. The data on the P.11 proteins of FA1090
are consistent with the identification of the extreme N-
terminus of the P.11 proteins as a semivariable region (25),
the variation being sufficient to generate a unique N-terminal
sequence for each P.11 protein.
Our efforts to purify the six P.11 proteins revealed differ-
ences in their behavior in chromatofocusing and hydro-
phobic interaction chromatography. Four of the P.11
proteins (P.IIa, P.IIb, P.IIe, and P.11f) were purified by
chromatofocusing. The membrane-associated nature of P.IIs
and the failure of P.IIc and P.IId to elute from the chromato-
focusing matrix led to our application of hydrophobic inter-
action chromatographic techniques. We devised two effi-
cient sgparation procedures that resulted in the purification
of P.IIc and P.IId, in single steps, on phenyl-Sepharose.
Requirements for extraction of P.lIc and P.IId from the
membrane were different, as were the conditions required
for adsorption to and elution from the phenyl-Sepharose
column. The structural differences affecting the chromato-
graphic properties of the proteins did not necessarily involve
the unique epitopes recognized by the monoclonal antibod-
ies. Proteins P.IIb and P.IId shared a common epitope, but
were clearly distinct proteins differing in apparent molecular
weight, N-terminal amino acid sequence, and opacity phe-
notype and bactericidal susceptibility of colonies expressing
them. P.IIb was readily purified by chromatofocusing chro-
matography, whereas P.IId purification required develop-
ment of a different method involving the use of phenyl-
Sepharose chromatography.
We do not know whether the significant differences in
behavior of FA1090 P.11 proteins on chromatofocusing and
phenyl-Sepharose chromatography reflect primary structural
differences or secondary interactions with other membrane
components, since the specific properties of membrane
proteins and detergents that affect protein behavior in dif-
ferent chromatographic systems are not well understood.
The hydrophobic interaction chromatography methods de-
scribed here have also proved useful for the purification of
other neisserial outer membrane proteins, such as the H.8
protein (unpublished results).
The P.II proteins of strain FA1090 differed structurally
and antigenically, with six unique N-terminal sequences and
five unique antigenic determinants among the six proteins.
They also differed in properties affecting their behavior
during extraction and purification. The existence of such
heterogeneity within this family of closely related proteins
reinforces the suggestion that specific P.11 proteins of a
gonococcal strain may have different functions. Some stud-
ies indicate that the expression of different P.II proteins of a
strain correlates with differences in properties such as ad-
herence or serum resistance (9, 18), and it is known that
expression of only some P.11 proteins correlates with
changes in colony opacity phenotype (1, 30, 32, 34). It will be
important to determine how the differences in primary
structure of P.11 proteins affect their organization in the
membrane and possible function in gonococcal infection.
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